Dr Lisa Marie Elazegui, PHARMD | |
102 Mount Olive Dr, Bradbury, CA 91008-1260 | |
(626) 357-6189 | |
Not Available |
Full Name | Dr Lisa Marie Elazegui |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 102 Mount Olive Dr, Bradbury, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134457294 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 61784 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Lisa Marie Elazegui, PHARMD 102 Mount Olive Dr, Bradbury, CA 91008-1260 Ph: () - | Dr Lisa Marie Elazegui, PHARMD 102 Mount Olive Dr, Bradbury, CA 91008-1260 Ph: (626) 357-6189 |
News Archive
Most patients with myelofibrosis, a rare chronic disorder of the haematopoietic cells of the bone marrow, benefit from drugs from the JAK2 inhibitor class: symptoms are relieved, survival extended and general quality-of-life enhanced.
New research in humans published today reveals that the so-called FKBP52 protein may prevent the Tau protein from turning pathogenic. This may prove significant for the development of new Alzheimer's drugs and for detecting the disease before the onset of clinical symptoms.
Forecasting changes in stock prices may be possible with the help of brain activity in regions associated with how people feel before making investment choices. Scientists could accurately forecast market price changes based on the average
In today's headlines, reports about presidential politics and health reform - most notably, Rick Perry's assault on Mitt Romney's Massachusetts record.
A widely used diabetes drug dramatically boosted the potency of platinum-based cancer drugs when administered together to a variety of cancer cell lines and to mice with tumors, scientists from Dana-Farber Cancer Institute report.
› Verified 1 days ago